You searched for CNS - Labiotech.eu

AI artificial intelligence dementia alzheimer's

News and Trends 13 Jun 2023

How AI can advance research and treatment of CNS disorders

…generation of treatments for diseases such as Alzheimer’s, Parkinson’s, and ALS. AI is revolutionizing drug discovery for CNS disorders AI has transformed the drug discovery process for CNS disorders by…

June 13, 2023 - 3 minutesmins - By External Contributor

Interview 25 Oct 2017

What Could RNA Therapies Do for the Treatment of CNS Disorders?

…led the charge as CEO to form Amylon. The company, based in Leiden and formed only last month, focuses on CNS disorders using an ultra-genetics approach. CNS research and companies…

October 25, 2017 - 3 minutesmins - By Alex Dale

News and Trends 23 Aug 2022

Gate Neurosciences emerges from stealth to tackle CNS diseases

…in 2019 by a team of neuroscience industry veterans to address the need for more effective treatments for CNS disorders, and to overcome long-standing challenges in CNS drug development. Since…

August 23, 2022 - 3 minutesmins - By Jim Cornall

More News! 14 Nov 2022

Minoryx and Neuraxpharm form alliance to get rights to new therapy for rare CNS disease

…new approach for Neuraxpharm. In this strategically relevant step, the company builds on its extensive CNS expertise stemming from 35 years in the field of CNS disorders. Neuraxpharm will create…

November 14, 2022 - 3 minutesmins - By Liza Laws

Startup Scout 13 Oct 2017

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

This week we’re in Castres in the South of France to visit Neurolixis. This biotech is taking on diseases of the CNS, such as Parkinson’s, depression and schizophrenia. Mission: Neurolixis…

October 13, 2017 - 2 minutesmins - By Alex Dale

News and Trends 18 Oct 2022

Empyrean Neuroscience launches with $22M to target CNS disorders

…system (CNS). The company, based in New York City and Cambridge, U.K., is founded on a proprietary platform designed to genetically engineer small molecule therapeutics from fungi and plants. Usman…

October 18, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 5 Jul 2022

EditForce and Mitsubishi Tanabi Pharma to work on gene therapy for CNS

…the central nervous system (CNS) by utilizing EditForce’s pentatricopeptide repeat (PPR) protein platform technology. MTPC and EditForce aim to create potential novel pharmaceuticals for the specific CNS disease by utilizing…

July 5, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 22 Sep 2022

Research identifies new treatment target for CNS injury and neurological disease

Researchers in Birmingham in the U.K. have identified a potential target for drugs to treat long-term neurological conditions like Alzheimer’s Disease and foster nerve regeneration in central nervous system injuries….

September 22, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 29 Sep 2022

NeuShen Therapeutics closes $20M pre-A financing

…and established.” CNS disorders CNS disorders are increasingly recognized as major causes of death and disability worldwide while the diagnosis and treatments have largely lagged. “Bringing breakthroughs and learnings from…

September 29, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Dec 2022

Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years

…company will provide differentiated and specialty generics in the Netherlands. This is a strategically important CNS pharmaceutical market in Europe. Neuraxpharm on path to number one CNS specialist Neuraxpharm Netherlands…

December 7, 2022 - 3 minutesmins - By Liza Laws

Best in Biotech 15 Aug 2024

10 neuroscience biotech companies you should know about

Developing treatments for neurological diseases presents a huge challenge for neuroscience companies within the biotech industry. The central nervous system (CNS) is extremely complex and many neurological diseases can be…

August 15, 2024 - 12 minutesmins - By Willow Shah-Neville

coronavirus COVID 19 Europe biotech lungs

News and Trends 25 Aug 2022

Alpha Biopharma announces completion of phase 2/3 clinical study for drug to treat lung cancer

…enrollment of 492 patients. The clinical and preclinical data of Zorifertinib have shown its high blood-brain barrier penetration, anti-tumor activity in metastatic CNS lesions, overall efficacy in both CNS and…

August 25, 2022 - 3 minutesmins - By Liza Laws

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: CNS

How AI can advance research and treatment of CNS disorders

What Could RNA Therapies Do for the Treatment of CNS Disorders?

Gate Neurosciences emerges from stealth to tackle CNS diseases

Minoryx and Neuraxpharm form alliance to get rights to new therapy for rare CNS disease

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

Empyrean Neuroscience launches with $22M to target CNS disorders

EditForce and Mitsubishi Tanabi Pharma to work on gene therapy for CNS

Research identifies new treatment target for CNS injury and neurological disease

NeuShen Therapeutics closes $20M pre-A financing

Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years

10 neuroscience biotech companies you should know about

Alpha Biopharma announces completion of phase 2/3 clinical study for drug to treat lung cancer

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!